SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $625,335 | -21.0% | 4,537 | -25.7% | 0.12% | -38.1% |
| Q4 2022 | $791,604 | +235.4% | 6,109 | +186.5% | 0.19% | +250.0% |
| Q3 2022 | $236,000 | +4.0% | 2,132 | -26.9% | 0.05% | -42.6% |
| Q2 2021 | $227,000 | -55.0% | 2,917 | -56.5% | 0.09% | -50.5% |
| Q3 2019 | $505,000 | +58.8% | 6,703 | +178.2% | 0.19% | -22.4% |
| Q2 2018 | $318,000 | -20.7% | 2,409 | -55.5% | 0.24% | -27.3% |
| Q1 2018 | $401,000 | – | 5,409 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |